Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase
Agents used to reduce adverse effects common in cancer treatment modalities do not typically possess tumor-suppressing properties. We report that heparanase, an extracellular matrix-degrading enzyme, is a promising candidate for preventing radiation nephropathy. Heparanase promotes tumor development...
Main Authors: | Alexia Abecassis, Esther Hermano, Kim Sheva, Ariel M. Rubinstein, Michael Elkin, Amichay Meirovitz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/11/3/710 |
Similar Items
-
Heparanase contributes to pancreatic carcinoma progression through insulin-dependent glucose uptake
by: Alexia Abecassis, et al.
Published: (2023-11-01) -
Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events
by: Valentina Masola, et al.
Published: (2018-11-01) -
Steroids and Malignancy Increase Local Heparanase and Decrease Markers of Osteoblast Activity in Bone Tissue Microcirculation
by: Keren Asayag, et al.
Published: (2024-11-01) -
Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice
by: Daisuke Katagiri, et al.
Published: (2024-11-01) -
Heparanase-1: From Cancer Biology to a Future Antiviral Target
by: Nadjet Lebsir, et al.
Published: (2023-01-01)